Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer — NEJM

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer — NEJM

瀏覽:1241
日期:2024-09-26
Original Article from The New England Journal of Medicine — Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer ... Results A total of 296 patients received treatment through February 24, 2012. Grade 3 or 4 drug-related adverse events ...看更多